Published

CNSC-36. PSILOCYBIN INDUCES SUSTAINED GLIOMA GROWTH THROUGH SEROTONERGIC AND TRKB PATHWAYS

An abstract is available from the original source but is not redistributed by this tracker. Read the source record.

Open source BibTeX RIS

Bibliographic context

Journal: Neuro-Oncology
Date: 2025-11-01
Source: OpenAlex
DOI: 10.1093/neuonc/noaf201.0244
PubMed: Unavailable

Authors

Richard Drexler Belgin Yalçın Rebecca Mancusi Abigail Rogers Kiarash Shamardani Pamelyn J. Woo Alexandre Ravel Yahaya A Yabo Carlos Alberto Oliveira de Biagi-Junior Costanza Lo Cascio Robert C. Malenka Boris D. Heifets Mariella G. Filbin Dieter Henrik Heiland Karl Deisseroth Michelle Monje

Watch author

Derived topics and classifications

psilocybin Pharmacology Mechanism of Action Receptor Pharmacology Animal Study In Vitro Study Cancer Patients Animal Study

Citation graph

0 referenced DOIs found in stored source metadata. 1 indexed paper cite this DOI.

Open citation network

Indexed papers citing this DOI

CNSC-36. PSILOCYBIN INDUCES SUSTAINED GLIOMA GROWTH THROUGH SEROTONERGIC AND TRKB PATHWAYS2025-11-01

Related papers

Could psilocin rescue chronic, stress-accelerated, transcriptional aging in brain?UKnowledge (University of Kentucky) · 2025-03-04 Why N,N-dimethyltryptamine matters: unique features and therapeutic potential beyond classical psychedelicsFrontiers in Psychiatry · 2024-11-06 Psilocybin may help cancer patients with depression and anxiety for yearsAccess Science · 2020-01-01 The Utility of Psilocybin in Managing Anxiety and Depression in Cancer PatientsBiochemistry and Molecular Biology Education · 2018-08-01 LSD Treatment in Persons Suffering From Anxiety Symptoms in Severe Somatic Diseases or in Psychiatric Anxiety Disorders: a Randomized, Double-blind, Placebo-controlled Phase II StudyClinicalTrials.gov · 2021-12-22